当前位置: 首页 > 期刊 > 《中国医学创新》 > 2025年第17期
编号:2390354
痉痹方对气滞血瘀型轻度脊髓型颈椎病患者临床疗效及生活质量的改善效果
http://www.100md.com 2025年8月14日 中国医学创新 2025年第17期
    

    The Clinical Eficacy and Quality of Life Improvement of Jingbi Formula in Patients with Mild Cervical Spondylotic Myelopathy of Qi Stagnation and Blood Stasis Type/SONG Zhipeng, GONG Zheng, ZHUJiyang,MENGWeiwei.//Medical Innovation of China,2025,22(17): 010-014

    [Abstract]Objective: To study the clinical efficacy of Jingbi Formula on mild cervical spondylotic myelopathy(CSM)of Qi stagnation and blood stasis type and its effectonimproving thequalityoflife.Method:From January 2O23 to June 2O24,eighty patientswith mild CSMof Qi stagnation and blood stasis type in Tianshan Traditional Chinese Medicine Hospital,Changning District,Shanghai were selectedas thestudyobjects,they were divided into study group(n=40)and control group (n=40) by random number table method.Patients in both groups weretreated with basic treatment after admission,the control group Was treated with Mecobalamin Tablets atthe same time,and the study group was treated with Jingbi Formulaat the same time.The treatment effctsand adverse reactions of the two groups were recorded ......

您现在查看是摘要页,全文长 15190 字符